Stemline Therapeutics, Inc. EBITDA Margin 2013-2020 | STML
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Stemline Therapeutics, Inc. (STML) over the last 10 years. The current EBITDA margin for Stemline Therapeutics, Inc. as of March 31, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-03-31 | $0.05B | $-0.08B | -159.57% |
| 2019-12-31 | $0.04B | $-0.08B | -188.37% |
| 2019-03-31 | $0.01B | $-0.10B | -1583.33% |
| 2018-06-30 | $0.00B | $-0.08B | -7600.00% |
| 2017-12-31 | $0.00B | $-0.07B | inf% |
| 2017-09-30 | $0.00B | $-0.06B | inf% |
| 2017-06-30 | $0.00B | $-0.05B | inf% |
| 2017-03-31 | $0.00B | $-0.04B | inf% |
| 2016-12-31 | $0.00B | $-0.04B | inf% |
| 2016-09-30 | $0.00B | $-0.04B | inf% |
| 2016-06-30 | $0.00B | $-0.04B | inf% |
| 2016-03-31 | $0.00B | $-0.04B | inf% |
| 2015-12-31 | $0.00B | $-0.04B | inf% |
| 2015-09-30 | $0.00B | $-0.03B | inf% |
| 2015-06-30 | $0.00B | $-0.03B | inf% |
| 2015-03-31 | $0.00B | $-0.03B | inf% |
| 2014-12-31 | $0.00B | $-0.03B | inf% |
